523 related articles for article (PubMed ID: 33503302)
21. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
Tsioufis K; Douma S; Kallistratos MS; Manolis AJ
Clin Drug Investig; 2019 Apr; 39(4):385-393. PubMed ID: 30790132
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Punzi H; Shojaee A; Maa JF;
Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):149-61. PubMed ID: 22855062
[TBL] [Abstract][Full Text] [Related]
23. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
Lewin AJ; Izzo JL; Melino M; Lee J; Fernandez V; Heyrman R
Drugs Aging; 2013 Jul; 30(7):549-60. PubMed ID: 23549909
[TBL] [Abstract][Full Text] [Related]
24. Guidelines-based therapeutic strategies for controlling hypertension in non-controlled hypertensive patients followed by family physicians in primary health care in Portugal: the GPHT-PT study.
Polónia J; Marques Pereira R
Blood Press; 2024 Dec; 33(1):2345887. PubMed ID: 38680045
[TBL] [Abstract][Full Text] [Related]
25. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
Levi M; Pasqua A; Cricelli I; Cricelli C; Piccinni C; Parretti D; Lapi F
J Manag Care Spec Pharm; 2016 Mar; 22(3):255-62. PubMed ID: 27003555
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.
Kim BJ; Cha KS; Cho WH; Kim EJ; Choi SH; Kim MH; Kim SH; Park JB; Park SM; Sohn IS; Ryu KH; Chae IH
J Cardiovasc Pharmacol Ther; 2023; 28():10742484231205204. PubMed ID: 37814541
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
[TBL] [Abstract][Full Text] [Related]
28. Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.
Odili AN; Ezeala-Adikaibe B; Ndiaye MB; Anisiuba BC; Kamdem MM; Ijoma CK; Kaptue J; Boombhi HJ; Kolo PM; Shu EN; Thijs L; Staessen JA; Omotoso BA; Kingue S; Ba SA; Lemogoum D; M'Buyamba-Kabangu JR; Ulasi II
Trials; 2012 May; 13():59. PubMed ID: 22594907
[TBL] [Abstract][Full Text] [Related]
29. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Oh J; Kim W; Kim GH; Kim HL; Park SD; Min KW; Hyun D; Hong JH; Lim S; Shin J;
Adv Ther; 2023 Nov; 40(11):4817-4835. PubMed ID: 37651078
[TBL] [Abstract][Full Text] [Related]
30. 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.
Izzo JL; Chrysant SG; Kereiakes DJ; Littlejohn Iii T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
J Clin Hypertens (Greenwich); 2011 Dec; 13(12):873-80. PubMed ID: 22142346
[TBL] [Abstract][Full Text] [Related]
31. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
Huan Y; Townsend R
Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
[TBL] [Abstract][Full Text] [Related]
32. Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
Rea F; Morabito G; Savaré L; Pathak A; Corrao G; Mancia G
J Hypertens; 2023 Sep; 41(9):1466-1473. PubMed ID: 37432906
[TBL] [Abstract][Full Text] [Related]
33. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.
Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
Circ J; 2012; 76(6):1415-22. PubMed ID: 22447014
[TBL] [Abstract][Full Text] [Related]
34. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
[TBL] [Abstract][Full Text] [Related]
35. Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
Fogari R; Zoppi A; Mugellini A; Preti P; Perrone T; Maffioli P; Derosa G
Expert Opin Pharmacother; 2012 Apr; 13(5):629-36. PubMed ID: 22372508
[TBL] [Abstract][Full Text] [Related]
36. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Eur J Pharm Sci; 2014 Jan; 51():26-33. PubMed ID: 23999037
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
[TBL] [Abstract][Full Text] [Related]
38. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
[TBL] [Abstract][Full Text] [Related]
39. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial.
King JB; Derington CG; Herrick JS; Jacobs JA; Zheutlin AR; Conroy MB; Cushman WC; Bress AP
Hypertension; 2023 Aug; 80(8):1749-1758. PubMed ID: 37288570
[TBL] [Abstract][Full Text] [Related]
40. Triple-combination therapy in the treatment of hypertension: a review of the evidence.
Düsing R; Waeber B; Destro M; Santos Maia C; Brunel P
J Hum Hypertens; 2017 Aug; 31(8):501-510. PubMed ID: 28230062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
